Contraception (Birth Control) and Family Planning PubHealthInfo

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]

Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

YEAR: 1973

CATEGORY: Contraception (Birth Control) and Family Planning

TITLE

Until conception, contraception with Norinyl. (Advertisement) s on the

serum gonadotropin levels in pre- and postmenopausal.

AUTHORS

Syntex Laboratories

SOURCE

American Journal of Obstetrics and Gynecology 115(1): 1-2. January 1, 1973.

ABSTRACT

Norinyl 1+50 oral contraceptive pills contain 1 mg of the progestin, norethindrone, and .05 mg (or 50 mcg) of the

estrogen, mestranol. These pills can either be taken in 21-day or 28-day therapy cycles. This dosage is low but

effective. Oral contraception is supposed to prevent pregnancy by suppressing ovulation and by causing changes in

the endometrium and cervical mucus. Contraindications are: 1) a history of thrombosis or cerebral disorders, 2) liver

dysfunction, 3) suspected breast cancer, 4) suspected estrogen-dependent neoplasia, and 5) undiagnosed

abnormal genital bleeding. Close surveillance of women taking oral contraceptives is recommended. The areas to be

closely examined periodically are listed. Adverse reactions and warning signs are enumerated. A warning is issued

of increased risk of the following conditions due to oral contraceptive therapy: 1) thrombotic disorders, 2) neuroocular

lesions, and 3) fluid retention and hypertension. (PubHealth.info Document ID: CONT8T 59-06)

PubHealth.info NOTE: The author(s) of this article titled, "Until conception, contraception with Norinyl.

(Advertisement) s on the serum gonadotropin levels in pre- and postmenopausal.", is(are) Syntex Laboratories. The

source of this article is "American Journal of Obstetrics and Gynecology 115(1): 1-2. January 1, 1973.". This article

was published in 1973 in English language(s). (PubHealth.info® Document ID: CONT8T 59-06. All rights reserved

with PubHealth.info) PIN: 35059

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.